FredericJoelReuMD

PubMed

• 1 citations
  Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospec...
  Yumeng Zhang, Lauren Duncanson, Jason Brayer, Frederic Reu, Doris Hansen, Melissa Alsina, Taiga Nishihori, Jose Ochoa-Bayona, Hien Liu, Kenneth Shain, Zachary Thompson...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Aug 1
• 10 citations
  Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.
  Metis Hasipek, Dale Grabowski, Yihong Guan, Raghunandan Reddy Alugubelli, Anand D. Tiwari, Xiaorong Gu, Gabriel DeAvila, Ariosto S. Silva, Mark B. Meads, Yvonne Parker...> ;Cancers. 2021 May 28
• 7 citations
  DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone ...
  Jack Khouri, Beth Faiman, Dale Grabowski, Reda Z. Mahfouz, Shahper N. Khan, Wei Wei, Jason Valent, Robert M. Dean, Christy J. Samaras, Babal K. Jha, Hillard M. Lazarus...> ;Seminars in Hematology. 2021 Jan 1
• 88 citations
  Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) wit...
  Brian G.M. Durie, Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein, S. Vincent Rajkumar, Angela Dispenzieri, Stephen P. Kahanic, Mohan C. Thakuri, Freder...> ;Blood Cancer Journal. 2020 May 11
• 1 citations
  Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multip...
  Jack Khouri, Frederic J. Reu, Navneet S. Majhail, Aaron T. Gerds, Deepa Jagadeesh, Robert M. Dean, Ronald Sobecks, Betty K. Hamilton, Brad Pohlman, Brian T. Hill, Donn...> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Apr 8
• 41 citations
  Daratumumab proves safe and highly effective in AL amyloidosis.
  Jack Khouri, Andrew Kin, Bicky Thapa, Frederic J. Reu, Naresh Bumma, Christy J. Samaras, Hien D. Liu, Mary Ann Karam, Janice Reed, Saveta Mathur, Beth Faiman, Georgia ...> ;British Journal of Haematology. 2019 Apr 1
• 99 citations
  Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
  Yi Hu, Jianhong Lin, Hua Fang, Jing Fang, Chen Li, Wei Chen, Shuang Liu, Sarah Ondrejka, Zihua Gong, Frederic J Reu, Jaroslaw P. Maciejewski, Qing Yi, Jianjun Zhao> ;Leukemia. 2018 Mar 22
• 18 citations
  Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.
  Surbhi Sidana, Mayur Narkhede, Paul Elson, Debbie Hastings, Beth Faiman, Jason Valent, Christy J. Samaras, Kimberly Hamilton, Hien Liu, Mitchell R. Smith, Frederic J. Reu> ;Plos One. 2017 Mar 9
• 572 citations
  Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autolo...
  Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J. Reu, Christopher M. Reynolds, ...> ;Lancet. 2017 Feb 4
• 211 citations
  Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
  Shaji Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henry C. Fung, Cristina...> ;Journal of the National Comprehensive Cancer Network. 2017 Feb 1
• 16 citations
  Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
  Hongmei Luo, Yu Qin, Frederic J. Reu, Sujuan Ye, Yang Dai, Jingcao Huang, Fangfang Wang, Dan Zhang, Ling Pan, Huanling Zhu, Yu Wu, Ting Niu, Zhijian Xiao, Yuhuan Zheng...> ;Journal of Hematology & Oncology. 2016 Nov 17
• 6 citations
  Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.
  Rachid C. Baz, Jeffrey A. Zonder, Cristina Gasparetto, Frederic J. Reu, Vincent Strout> ;Oncology and Therapy. 2016 Nov 2
• 34 citations
  Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
  Yuhuan Zheng, Qiang Wang, Tianshu Li, Jianfei Qian, Yong Lu, Yi Li, Enguang Bi, Frederic J. Reu, Yu Qin, Judy Drazba, Eric D. Hsi, Jing Yang, Zhen Cai, Qing Yi> ;Journal of the National Cancer Institute. 2016 Nov 1
• 64 citations
  Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.
  Sergei Vatolin, James G. Phillips, Babal K. Jha, Shravya Govindgari, Jennifer C Hu, Dale Grabowski, Yvonne Parker, Daniel J. Lindner, Fei Zhong, Clark W. Distelhorst, ...> ;Cancer Research. 2016 Jun 1
• 51 citations
  NCCN guidelines® insights multiple myeloma, version 3.2016 featured updates to the NCCN guidelines
  Kenneth C. Anderson, M. Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Benjamin Djulbegovic, Henry C. Fung, Cristina Gasparetto, ...> ;Journal of the National Comprehensive Cancer Network. 2016 Apr 1
• 5 citations
  Structural Optimization of Non-Nucleoside DNA Methyltransferase Inhibitor as Anti-Cancer Agent
  Bo Zhong, Sergei Vatolin, Nethrie D. Idippily, Rati Lama, Laila Abdulmohsen Alhadad, Frederic J. Reu, Bin Su> ;Bioorganic & Medicinal Chemistry Letters. 2016 Feb 15
• 3 citations
  Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy
  Sanghee Hong, Jason Valent, Lisa Rybicki, Donna Abounader, Brian J. Bolwell, Robert M. Dean, Aaron T. Gerds, Deepa Jagadeesh, Betty K. Hamilton, Brian T. Hill, Matt Ka...> ;Bone Marrow Transplantation. 2016 Jan 4
• 55 citations
  A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting...
  Andrew R. Lavik, Fei Zhong, Ming-Jin Chang, Edward F Greenberg, Yuvraj Choudhary, Mitchell R. Smith, Karen S. McColl, John J. Pink, Frederic J. Reu, Shigemi Matsuyama,...> ;Oncotarget. 2015 Jul 13
• 59 citations
  Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
  Yi Li, Yuhuan Zheng, Tianshu Li, Qiang Wang, Jianfei Qian, Yong Lu, Mingjun Zhang, Enguang Bi, Maojie Yang, Frederic J. Reu, Qing Yi, Zhen Cai> ;Oncotarget. 2015 Jun 20
• 58 citations
  Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
  Yogen Saunthararajah, Mikkael A. Sekeres, Anjali S. Advani, Reda Z. Mahfouz, Lisa Durkin, Tomas Radivoyevitch, Ricki Englehaupt, Joy Juersivich, Kathleen Cooper, Holle...> ;The Journal of Clinical Investigation. 2015 Mar 2
• 8 citations
  Mature results of MM‐011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide mainte...
  Aleksandr Lazaryan, Mohamad A. Hussein, Frederic J. Reu, Beth Faiman, Becky Habecker, Mary Ann Karam, Janice Reed, Kimberly Hamilton, Joel Waksman, Kellie Bruening, Go...> ;American Journal of Hematology. 2014 Apr 1
• 108 citations
  Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
  Shahper N. Khan, Anna M. Jankowska, Reda Z. Mahfouz, Andrew Dunbar, Yuka Sugimoto, Naoko Hosono, Zhenbo Hu, Venugopalan Cheriyath, Sergei Vatolin, Bartlomiej P Przycho...> ;Leukemia. 2013 Jun 1
• 81 citations
  Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
  Christoph Heuck, Jayesh Mehta, Tushar D. Bhagat, Krishna Gundabolu, Yiting Yu, Shahper N. Khan, Grigoris Chrysofakis, Carolina Schinke, Joseph D. Tariman, Eric Vickrey...> ;Journal of Immunology. 2013 Mar 15
• 67 citations
  Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
  Andrzej Jakubowiak, David S. Siegel, Thomas Martin, Michael Wang, Ravi Vij, Sagar Lonial, Suzanne Trudel, Vishal Kukreti, Nizar J. Bahlis, Melissa Alsina, Asher Chanan...> ;Leukemia. 2013 Jan 1
• 494 citations
  A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
  David S. Siegel, Thomas Martin, Michael Wang, Ravi Vij, Andrzej Jakubowiak, Sagar Lonial, Suzanne Trudel, Vishal Kukreti, Nizar J. Bahlis, Melissa Alsina, Asher Chanan...> ;Blood. 2012 Oct 4
• Join now to see all